Skip to content

biomarkers in the diagnosis and prognosis in septic acute kidney injury

Serum and urine biomarkers are compared in septic patients with acute renal injury to nonseptic, non acute renal injury in surgical ICU setting

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12614001284651
Enrollment
25
Registered
2014-12-09
Start date
2014-11-03
Completion date
2015-06-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Severe sepsis is one of the leading causes of acute kidney injury (AKI). Of patients with sepsis in the ICU, 31–61% have AKI. Both the incidence of severe sepsis and AKI are increasing. Patients with septic AKI have worse outcome than septic patients without AKI in terms of longer ICU and hospital stays and higher mortality. Because the current RIFLE classification does not integrate biomarkers for early diagnosis, severity staging and predicting prognosis of AKI, the present study will be conducted to determine the association between some biomarkers in predicting the progression or recovery of septic AKI.

Interventions

Urine samples will be collected from existing foley cathethers and blood samples collected from arterial catheters from enrolled patients who are recognized as having sepsis with acute renal injury, from admission and every other day for up to 10 days or until these patients are discharged to ward from ICU or deceased.

Sponsors

Dr. Hsin-I Tsai
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

>18 years old without known previous renal diseases admitted to our surgical ICU in the absence of any one of the exclusion criteria

Exclusion criteria

1. Urinary tract infection on admission 2. Chronic kidney disease (glomerular filtration rate <60ml/min/1.73m2) for more than 3 months) 3. Patients requiring routine dialysis program 4. Renal transplantation 5. Inflammatory bowel disease

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026